Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-2103 (Xyotax) in Recurrent Ovarian/Peritoneal Cancer
NCT00045682Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Sep 2002
- Primary completion
- Jul 2006
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Sep 2002; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00045682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045682.